Keywords: pharmacyclics, start, new, trial, xcytrin, firm, said

Pharmacyclics to start new trial of Xcytrin

Article | 22 April 2002

Print This

US firm Pharmacyclics has said it will start an additional Phase IIIclinical trial of its lead product, Xcytrin (motexafin gadolinium) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in